H. Lundbeck A/S (Lundbeck) today presented new real-world 6-month results from the INFUSE study at the American Academy of Neurology (AAN) ...

ALXN1840 has demonstrated a well-characterized and favorable safety profile across Phase 2 and Phase 3 studies (266 patients; median 2.58 years on treatment; max >8 years), with drug-related serious ...

A Cell Perspective argues that generative AI models could help tackle cancer’s multiscale, multimodal complexity by ...

Water quality at England's largest lake will be monitored non-stop in a 12-month trial to test the equipment and process ...

Following President Trump's promise of mass deportations of undocumented immigrants, more than 200 immigration judges have ...

VYEPTI is indicated for the preventive treatment of migraine in adults. VYEPTI is contraindicated in patients with serious hypersensitivity to eptinezumab-jjmr or to any of its ingredients. Reactions ...

Technion researchers part of international study that validates fast, accessible alternative to genomic tests using routine ...

PLEASANTON, Calif., April 18, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial ...

Harmful sugar made by gut bacteria can trigger immune damage connected to two devastating brain diseases. This data points to ...

For years, physicists have treated knowledge as a kind of fuel in the quantum ...

One fascinating creature spends its winters beneath four feet of Antarctic sea ice, diving to nearly 2,000 feet in water cold ...

Discover why Gen Z demands more than just profit. Learn how a purpose-driven brand strategy builds long-term trust, loyalty, ...